Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Extranodal lymphoma of lymphoid tissue associated with mucosa that is in contact with exogenous antigens. Many of the sites of these lymphomas, such as the stomach, salivary gland, and thyroid, are normally devoid of lymphoid tissue. They acquire mucosa-associated lymphoid tissue (malt) type as a result of an immunologically mediated disorder.
Biomarker and diagnostic research for primary cutaneous marginal zone B-cell lymphoma has been reported in the published literature.
No clinical trials have been registered for primary cutaneous marginal zone B-cell lymphoma.
11 publications have been identified in PubMed for primary cutaneous marginal zone B-cell lymphoma. Research spans Review / Meta-Analysis (27%), Diagnostic / Biomarker (18%), and Case Report / Case Series (18%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 3 | 27% |
Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 3:00 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Testing and diagnosis research
2 |
18% |
Patient case studies | 2 | 18% |
Laboratory research | 2 | 18% |
Disease patterns and progression | 2 | 18% |
Donzel M (2026). [PMID: 41720645](https://pubmed.ncbi.nlm.nih.gov/41720645/). *Annales de pathologie*. [Case Report / Case Series]
Griss J (2026). [PMID: 41639106](https://pubmed.ncbi.nlm.nih.gov/41639106/). *Nature communications*. [Basic Science / Preclinical]
Gupta R (2026). [PMID: 41839018](https://pubmed.ncbi.nlm.nih.gov/41839018/). *Cutis*. [Review / Meta-Analysis]
Chen GP (2025). [PMID: 40586267](https://pubmed.ncbi.nlm.nih.gov/40586267/). *Journal of investigative surgery : the official journal of the Academy of Surgical Research*. [Review / Meta-Analysis]
Rubio-Aguilera RF (2025). [PMID: 40081481](https://pubmed.ncbi.nlm.nih.gov/40081481/). *Actas dermo-sifiliograficas*. [Diagnostic / Biomarker]
Alawadhi J (2025). [PMID: 40979025](https://pubmed.ncbi.nlm.nih.gov/40979025/). *Cureus*. [Basic Science / Preclinical]
Kluger N (2024). [PMID: 39047656](https://pubmed.ncbi.nlm.nih.gov/39047656/). *Annales de dermatologie et de venereologie*. [Case Report / Case Series]
Paudel U (2024). [PMID: 39328103](https://pubmed.ncbi.nlm.nih.gov/39328103/). *Kathmandu University medical journal (KUMJ)*. [Epidemiology / Natural History]
Ciolfi C (2024). [PMID: 39295875](https://pubmed.ncbi.nlm.nih.gov/39295875/). *Dermatology reports*. [Diagnostic / Biomarker]
Goules AV (2024). [PMID: 39182505](https://pubmed.ncbi.nlm.nih.gov/39182505/). *The Lancet. Rheumatology*. [Epidemiology / Natural History]
AI-curated news mentioning primary cutaneous marginal zone B-cell lymphoma
Updated May 10, 2026
A recent study highlights plasmablastic lymphoma presenting with multiple cutaneous nodules, which can be mistaken for primary cutaneous marginal zone lymphoma. This research contributes to the understanding of differential diagnoses in rare lymphomas.
Recent research indicates that indolent primary cutaneous B-cell lymphomas exhibit characteristics similar to persistent antigen reactions, lacking signs of dedifferentiation. This finding may influence future diagnostic and therapeutic strategies for this rare lymphoma subtype.